Glaucoma Clinical Trial
— gVRTOfficial title:
Vision Restoration Training in Glaucoma - A Double-blind, Randomized, Placebo-controlled Clinical Trial
| NCT number | NCT01799707 |
| Other study ID # | VRT 03-2003 |
| Secondary ID | |
| Status | Completed |
| Phase | Phase 2 |
| First received | |
| Last updated | |
| Start date | July 2004 |
| Est. completion date | March 2013 |
| Verified date | July 2019 |
| Source | University of Magdeburg |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Importance: Visual field loss after retinal damage in glaucoma is considered irreversible and
methods are needed to achieve vision restoration. Behavioral vision restoration training
(VRT), shown to improve visual fields in hemianopia and optic nerve damage, might comprise
such a method.
Objective: To determine if behaviorally activating areas of residual visual (ARV) using VRT
by daily one hour training for 3 months improves detection performance in perimetry compared
to a vision discrimination task in the intact visual field sector.
| Status | Completed |
| Enrollment | 30 |
| Est. completion date | March 2013 |
| Est. primary completion date | August 2007 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 25 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - Visual filed defect caused by glaucoma - Presence of a reproducible and stable visual field defect inside 30° eccentricity in at least one eye in 2 consecutive ophthalmologic visits during the last 12 months before recruitment - Well controlled intraocular pressure (IOP), and (iv) age between 25 and 80 years Exclusion Criteria: - History of any medical condition precluding scheduled study visits or completion of the study (e.g. unstable cardiovascular disease) - History of any chronic degenerative or chronic inflammatory disease that could affect the visual field (e.g. multiple sclerosis, tumor - History of trauma or any non-glaucoma ocular diseases (e.g. diabetic retinopathy, age-related macular degeneration, macular detachment, vascular occlusion - Severe cognitive or motor impairments - Insufficient fixation ability - Photosensitivity - Intraocular surgery or laser treatment performed within the previous 12 months before recruitment; OR - Scheduled intraocular surgery |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University of Magdeburg |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Eye movement control | visual stimulus detection in residual and absolutely defect field of vision will be assessed using computer-based high resolution perimetry (HRP) | between baseline and 3 months of training | |
| Primary | Detection accuracy change in percent over baseline of the visual field | visual stimulus detection in residual and absolutely defect field of vision will be assessed using computer-based high resolution perimetry (HRP) | between baseline and 3 months of training | |
| Secondary | change in visual stimulus perimetric detection rate | improvement of visual field in near-threshold perimetry measured by static perimetry (average threshold in db, average excentricity in degrees of visual angle | between baseline and 3 months of training | |
| Secondary | improvement of reaction time | change in average reaction time in ms, measured by HRP | between baseline and 3 months of training |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
| Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
| Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
| Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
| Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
| Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
| Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
| Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
| Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
| Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
| Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
| Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
| Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
| Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
| Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
| Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
| Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
| Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
| Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
| Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A |